Ortho Clinical Diagnostics
100 Indigo Creek Drive
Rochester
New York
14626
United States
Tel: 800-828-6316
Fax: 585-453-3660
Website: http://www.orthoclinical.com/
121 articles about Ortho Clinical Diagnostics
-
Ortho Clinical Diagnostics Launches Ortho's VITROSĀ® C-peptide Assay
3/8/2018
Assay is now commercially available in the U.S. and countries accepting CE Mark
-
Ortho Clinical Diagnostics Release: A New & Novel Method for the Measurement of Alanine Aminotransferase (ALT) From Ortho Clinical Diagnostics is Now Available
12/19/2017
ALT is used in the diagnosis and treatment of certain liver diseases as well as heart diseases.
-
VITROS HIV Combo detects both HIV-1 and HIV-2 antibodies and the p24 antigen, enabling HIV-1 acute infection detection earlier than third-generation tests.
-
Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure
12/7/2017
The agreement allows Ortho to use the sphingotest bio-ADM immunoassay on Ortho's automated VITROS Immunodiagnostics and Integrated Systems for small, mid- and high-volume clinical laboratories.
-
The companies are ranked by revenues of clinical diagnostic test instruments, reagents and supplies.
-
CFDA Approves ORTHO VISION Platform for Transfusion Medicine Labs
10/25/2017
Ortho Clinical Diagnostics today announced that its ORTHO VISION Platform of fully automated blood analyzers for low-, mid- and high-volume transfusion medicine laboratories has received approval by the CFDA.
-
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics And EKF diagnostic GmbH
10/12/2017
-
Ortho Clinical Diagnostics Release: New NephroCheck Test Outcomes Data Show Significant Reduction In Kidney Injury, Hospital Stay
9/26/2017
-
Ortho Clinical Diagnostics Release: FDA Licenses ORTHO Sera Designed For Extended Phenotype Testing For Use With Ortho ID-MTS Gel Card Technology
8/28/2017
-
Ortho Clinical Diagnostics Announces Global Agreement To Make B.R.A.H.M.S PCT Assay Available To Ortho Customers
7/31/2017
-
Ortho Clinical Diagnostics Nabs FDA 510(k) Clearance for Its VITROS Insulin Reagent & Calibrators
6/26/2017
-
Quotient Limited And Ortho Clinical Diagnostics To Present Symposium On Role Of Extended Phenotyping In Blood Matching At ISBT
6/23/2017
-
Ortho Clinical Diagnostics VITROS NephroCheck Test For Prediction Of Acute Kidney Injury Cleared, Available In Europe
6/7/2017
-
Ortho Clinical Diagnostics VITROS NephroCheck Test For Prediction Of Acute Kidney Injury Cleared, Available In Europe
6/6/2017
-
Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test
3/13/2017
-
Astute Medical Expands Relationship With bioMerieux SA And Ortho Clinical Diagnostics To Enhance NephroCheck Test Market Access
3/13/2017
-
Ortho Clinical Diagnostics Submits VITROS Immunodiagnostic Products HIV Combo Assay To FDA For Review; Applies To Expand Use Of Specialty Hepatitis Assays
2/23/2017
-
Ortho Clinical Diagnostics Release: Company Receives CE Mark Approval For ORTHO CONNECT V2.0 Middleware Solution
1/11/2017
-
FDA Clears VITROS Automation Solutions From Ortho Clinical Diagnostics
10/28/2016
-
FDA Clears Ortho Clinical Diagnostics' ORTHO VISION Max Analyzer for High-Volume Transfusion Medicine Labs
10/24/2016